0 NYSE Companies - November 11, 2024Regional Health Properties, Inc. Announces Receipt of NYSE American Notice of Delisting and Intention to AppealATLANTA, GA, Nov. 11, 2024 (GLOBE NEWSWIRE) — Regional Health Properties, Inc. (the “Company,” “we” or “our”) (NYSE American: RHE) […]Read More
0 NASDAQ Companies - November 11, 2024Gentherm Announces Updated Fireside Chat Time for 2024 Baird Global Industrial ConferenceNORTHVILLE, Mich., Nov. 11, 2024 (GLOBE NEWSWIRE) — Gentherm (NASDAQ: THRM), the global market leader of innovative thermal management and pneumatic […]Read More
0 NASDAQ Companies - November 11, 2024MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-NovartisLA JOLLA, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market […]Read More
0 TSX News - November 11, 2024Titanium Transportation Group Reports Steady Q3 2024 Performance with 24% Increase in Volume in Logistics SegmentConsolidated third quarter revenue grew by 5.1% compared to the previous year, driven by strong performance in the Logistics segment […]Read More
0 NYSE Companies - November 11, 2024Serina Therapeutics Makes Grants to New Employees Under Inducement PlanHUNTSVILLE, AL, Nov. 11, 2024 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its […]Read More
0 NASDAQ Companies - November 11, 2024NEXGEL Announces $2,000,000 Registered Direct OfferingLANGHORNE, Pa., Nov. 11, 2024 (GLOBE NEWSWIRE) — NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of […]Read More
0 TSX Venture News - November 11, 2024Crown Point Announces Operating and Financial Results for the Three and Nine Months Ended September 30, 2024CALGARY, Alberta, Nov. 11, 2024 (GLOBE NEWSWIRE) — TSX-V: CWV: Crown Point Energy Inc. (“Crown Point”, the “Company” or “we“) […]Read More
0 NASDAQ Companies - November 11, 202423andMe Announces Business Restructuring to Streamline Operations, Reduce Costs and Position Company for the FutureReduces workforce by roughly 40%; expects annualized cost savings of more than $35 million Discontinues development of therapeutics division and […]Read More